Nancy Leahy
Adult Health · Philadelphia, PANPI 1639170061
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 55 payments — averaging $97.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Jazz Pharmaceuticals Inc.$407
- Boehringer Ingelheim$354
- E.r. Squibb & Sons, L.L.C.$302
- Gilead$242
- Daiichi Sankyo Inc.$228
- plus $3K from 25 others
What the payments were for
- Food & beverage$5,386100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 10 | $1,069 |
| Jazz Pharmaceuticals Inc. | 4 | $407 |
| Boehringer Ingelheim | 3 | $354 |
| E.r. Squibb & Sons, L.L.C. | 3 | $302 |
| Gilead | 2 | $242 |
| Daiichi Sankyo Inc. | 2 | $228 |
| Inspire Medical Systems, Inc. | 2 | $198 |
| Seagen Inc. | 2 | $189 |
| Insmed, Inc. | 2 | $187 |
| Johnson & Johnson | 2 | $183 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $152 |
| Bristol Myers Squibb | 1 | $125 |
| Averitas Pharma Inc. | 1 | $125 |
| Stemline Therapeutics Inc. | 1 | $125 |
| Lilly USA, LLC | 1 | $121 |
| Blueprint Medicines Corporation | 1 | $113 |
| Pfizer | 1 | $112 |
| Esperion Therapeutics, Inc. | 1 | $111 |
| Regeneron Healthcare Solutions, Inc. | 1 | $110 |
| GSK | 1 | $104 |
| Novocure Inc. | 1 | $95 |
| Laborie Medical Technologies Corp. | 2 | $93 |
| Paratek Pharmaceuticals, Inc. | 1 | $90 |
| Incyte Corporation | 1 | $85 |
| Boston Scientific | 1 | $77 |
| Sanofi | 1 | $75 |
| Sobi, Inc | 1 | $73 |
| Urovant Sciences Inc | 1 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $60 |
| AbbVie | 1 | $57 |
| Coloplast | 1 | $55 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,386 in reported general payments places this provider in the 90th percentile of 899 adult health providers in Pennsylvania.
Other adult health in Philadelphia
- Beth SandyPhiladelphia$924K
- Diane NewmanPhiladelphia$343K
- Abigail SmithPhiladelphia$302K
- Catherine HoldsworthPhiladelphia$64K
- Kevin CarneyPhiladelphia$53K
- Christine ChmielewskiPhiladelphia$52K
- Barbara RogersPhiladelphia$51K
- Joyce RossPhiladelphia$39K
- Veronica RichardsonPhiladelphia$33K
- Tetyana FurmanetsPhiladelphia$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.